Importance of the Infusion Rate for the Plasma Expanding Effect of 5% Albumin in the Septic Patient
NCT03153306 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60
Last updated 2017-05-15
Summary
Correction of hypovolemia is an important therapeutic measure,Even though there is no consensus regarding infusion rates, a plasma volume (PV) expander is often given at a fast rate to treat a suspected hypovolemia without delay which can be associated with aggravation of adverse interstitial accumulation of macromolecules and fluid, especially in inflammatory conditions such as sepsis.the smallest possible volumes for PV resuscitation to maintain normovolemia should be used to reduce the risk of simultaneous interstitial fluid accumulation. The investigators tested the hypothesis that a slow infusion rate of a PV expander results in better plasma expansion than a fast infusion rate to patients with severe sepsis or septic shock.
Conditions
Interventions
- DRUG
-
albumin
Two groups were formed at random for each fluid. In one group, 10ml/kg of 5% albumin was given over 1 hour (the "bolus" group), and in the other group, the same volume was given over 6 hrs (the"continuous" group)
Sponsors & Collaborators
-
Southern Medical University, China
collaborator OTHER -
Hainan People's Hospital
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-06-30
- Primary Completion
- 2017-12-31
- Completion
- 2018-03-31
Countries
- China
Study Locations
More Related Trials
-
Effect of Renin-Angiotensin System on Platelet in Patient With Sepsis
NCT03952390 ·Status: COMPLETED
-
The Effect of rTEM in the Prognosis and Severity of Sepsis Induced ARDS
NCT06063707 ·Status: NOT_YET_RECRUITING
-
Establishment of Early Diagnosis and Monitoring Model for Sepsis Patients
NCT04974411 ·Status: UNKNOWN
-
Neutrophil Elastase Inhibitor in Treatment of ARDS Patients With Mechanical Ventilation Caused by Sepsis
NCT05672472 ·Status: UNKNOWN ·Phase: NA
-
Protective Effect of Sivelestat Sodium on ARDS in Patients With Sepsis
NCT04973670 ·Status: UNKNOWN ·Phase: PHASE3
-
Clinical Research on Shenfu Injection in Septic Patients
NCT06157320 ·Status: RECRUITING ·Phase: NA
-
Effects of Fluid Therapy on Peripheral TIssse Perfusion During Sepsis/Septic Shock
NCT05094856 ·Status: COMPLETED
-
A Multicenter Cross-sectional Study of Cardiac Ultrasound Phenotypes in Patients With Sepsis
NCT05161104 ·Status: ENROLLING_BY_INVITATION
-
Early Albumin Resuscitation During Septic Shock
NCT00327704 ·Status: COMPLETED ·Phase: PHASE4
-
The Predictive Value of Hepatocyte Growth Factor and Soluble Receptor s-Met in Sepsis
NCT03340649 ·Status: UNKNOWN
-
Efficacy of Anisodamine Hydrobromide Combined With Low-molecular-weight Heparin in the Treatment of Patients With Sepsis
NCT05634057 ·Status: RECRUITING ·Phase: NA
-
Risk Factors for Adverse Outcomes in Sepsis
NCT06541600 ·Status: COMPLETED
-
The Effect of Increasing the Mean Arterial Pressure on the Microcirculation and the Prognosis of Patients With Septic Shock
NCT04136080 ·Status: UNKNOWN ·Phase: NA
-
The Role of NLR in the Diagnosis and Prognosis of Sepsis
NCT05636202 ·Status: COMPLETED
-
A Prediction Model of 28-day Mortality in Septic Shock
NCT04915625 ·Status: UNKNOWN
-
Epidemiology, Acute Management, and Outcomes of Patients With Sepsis Presenting to a Referral Hospital in Western Kenya
NCT02346331 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of Unfractionated Heparin on Severe Sepsis With Suspected Disseminated Intravascular Coagulation
NCT02654561 ·Status: RECRUITING ·Phase: PHASE3
-
The Effect of Lactate Clearance Oriented Haemodynamic Therapy on the Outcome of Patients With Septic Shock
NCT02566460 ·Status: COMPLETED ·Phase: NA
-
Construction of a Database for the Life-cycle Sepsis-specific Disease Cohort
NCT04872010 ·Status: UNKNOWN
-
Peripheral Artery Disease and Sepsis Outcomes
NCT03372330 ·Status: UNKNOWN
-
Volume Replacement With Albumin in Severe Sepsis
NCT00707122 ·Status: COMPLETED ·Phase: PHASE3
-
Urine Interleukin-37 as a Biomarker of Mortality Risk in Patients With Sepsis
NCT05640037 ·Status: COMPLETED
-
Early Identification and Effective Management of Pediatric Sepsis
NCT03996720 ·Status: COMPLETED
-
Correlation of VEGF-A and Fluid Balance in Septic Shock
NCT04474431 ·Status: COMPLETED ·Phase: NA
-
Serum Albumin Ratios Can Improve Sepsis Mortality Prediction
NCT06640504 ·Status: COMPLETED